ATE101621T1 - Reines protein und bioaktive pharmazeutische produkte. - Google Patents

Reines protein und bioaktive pharmazeutische produkte.

Info

Publication number: ATE101621T1
Authority: AT; Austria
Prior art keywords: subjected; pharmaceutical; stelazine; tamoxifen; embryos
Prior art date: 1989-11-13

Application number

AT90915915T

Other languages

English (en)

Inventor

Wojciech J Ardelt

Stanislaw M Mikulski

Original Assignee

Alfacell Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-13

Filing date

1990-10-26

Publication date

1994-03-15

1990-10-26 Application filed by Alfacell Corp filed Critical Alfacell Corp

1994-03-15 Application granted granted Critical

1994-03-15 Publication of ATE101621T1 publication Critical patent/ATE101621T1/de

Links

230000000975 bioactive effect Effects 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
229940127557 pharmaceutical product Drugs 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 abstract 4
210000004027 cell Anatomy 0.000 abstract 3
210000002257 embryonic structure Anatomy 0.000 abstract 2
238000000338 in vitro Methods 0.000 abstract 2
229960001603 tamoxifen Drugs 0.000 abstract 2
ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 abstract 2
206010052747 Adenocarcinoma pancreas Diseases 0.000 abstract 1
206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
241000270942 Rana pipiens Species 0.000 abstract 1
230000002378 acidificating effect Effects 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
235000013601 eggs Nutrition 0.000 abstract 1
230000004720 fertilization Effects 0.000 abstract 1
238000004255 ion exchange chromatography Methods 0.000 abstract 1
201000005296 lung carcinoma Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
210000004681 ovum Anatomy 0.000 abstract 1
201000002094 pancreatic adenocarcinoma Diseases 0.000 abstract 1
238000001542 size-exclusion chromatography Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Marine Sciences & Fisheries (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT90915915T 1989-11-13 1990-10-26 Reines protein und bioaktive pharmazeutische produkte. ATE101621T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US43614189A	1989-11-13	1989-11-13
US52631490A	1990-05-18	1990-05-18
EP90915915A EP0500589B1 (de)	1989-11-13	1990-10-26	Reines protein und bioaktive pharmazeutische produkte
PCT/US1990/006185 WO1991007435A1 (en)	1989-11-13	1990-10-26	Purified protein and bioactive pharmaceutical

Publications (1)

Publication Number	Publication Date
ATE101621T1 true ATE101621T1 (de)	1994-03-15

Family

ID=27030821

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90915915T ATE101621T1 (de)	1989-11-13	1990-10-26	Reines protein und bioaktive pharmazeutische produkte.

Country Status (4)

Country	Link
EP (1)	EP0500589B1 (de)
AT (1)	ATE101621T1 (de)
DE (1)	DE69006741T2 (de)
WO (1)	WO1991007435A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5728805A (en) *	1988-04-06	1998-03-17	Alfacell Corp.	Pharmaceuticals and method for making them
ATE145334T1 (de) *	1992-07-30	1996-12-15	Alfacell Corp	Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel
HU221407B1 (hu) *	1997-03-28	2002-09-28	Gyula Magvasi	Ektodermális eredetû szövetekben fellépõ tumoros burjánzást gátló hatóanyag és készítmény, valamint eljárás elõállításukra

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4882421A (en) *	1982-09-23	1989-11-21	Alfacell Corporation	Pharmaceutical for treating tumors and method for making it

1990
- 1990-10-26 DE DE69006741T patent/DE69006741T2/de not_active Expired - Lifetime
- 1990-10-26 AT AT90915915T patent/ATE101621T1/de not_active IP Right Cessation
- 1990-10-26 WO PCT/US1990/006185 patent/WO1991007435A1/en not_active Ceased
- 1990-10-26 EP EP90915915A patent/EP0500589B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0500589A1 (de)	1992-09-02
DE69006741T2 (de)	1994-06-01
DE69006741D1 (de)	1994-03-24
EP0500589B1 (de)	1994-02-16
WO1991007435A1 (en)	1991-05-30

Similar Documents

Publication	Publication Date	Title
SE8504945L (sv)	1986-04-23	Farmaceutiska kompositioner innehallande antracyklinglykosider
Pickart et al.	1987	[28] Biological activity of human plasma copper-binding growth factor glycyl-l-histidyl-l-lysine
ES2051806T3 (es)	1994-07-01	Preparados de proteina humana estables.
ATE194651T1 (de)	2000-07-15	Stammzellenfaktor
BR9809006A (pt)	2000-08-08	Composição, processo para produzir a mesma, processos de liberação de uma proteìna a uma célula de um indivìduo, de liberação de uma proteìna, polipeptìdeo, peptìdeo e/ou medicamentos não proteináceos/composto terapêutico a uma célula de um indivìduo, para induzir uma resposta imune em um indivìduo, para liberar uma molécula de ácido nucleico a uma célula de um indivìduo,e, composição farmacêutica
ES2147553T3 (es)	2000-09-16	Vectores virales recombinantes para la expresion en unas celulas musculares.
ZA884216B (en)	1989-02-22	Proteins with factor viii activity,process for their preparation and pharmaceutical compositions containing them
GB1531762A (en)	1978-11-08	Cancer antigen cancer therapy and cancer diagnosis
MY102472A (en)	1992-06-30	Preparation of funtional human urokinase proteins.
ATE54826T1 (de)	1990-08-15	Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ATE203997T1 (de)	2001-08-15	Antiwachstumwirksame proteine aus oozyten von rana pipiens
ATE98869T1 (de)	1994-01-15	Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.
EP0592566A4 (de)	1995-05-24	Cysteinfreie il-6 mutanten.
ATE101621T1 (de)	1994-03-15	Reines protein und bioaktive pharmazeutische produkte.
DE3063339D1 (en)	1983-07-07	Peptides with pharmacological activity and medicines containing them
EP0220453A3 (en)	1988-03-23	Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same
FI882891A0 (fi)	1988-06-16	Menetelmä angiogeenisen tekijän tuottamiseksi
DK107389D0 (da)	1989-03-06	Modificerede proteiner
ES2057008T3 (es)	1994-10-16	Medicamento.
White et al.	1984	Dantrolene and calcium uptake by the sarcoplasmic reticulum of malignant hyperpyrexia-susceptible pigs
Ruggeri et al.	1986	HEp-2 cells multinucleation induced by an E. coli cytotoxic factor.
YU64192A (sh)	1994-06-10	Analozi insulina
PT840794E (pt)	2006-07-31	Medicamento contendo pelo menos uma parte da proteina ul84 do citomegalovirus, utilizacao de polipeptideos de acordo com a sequencia do aminoacido da proteina ul84 e processo para a introducao de ul84 em celulas alvo
ES482162A1 (es)	1980-04-01	Procedimiento para la obtencion de hormonas, vitaminas y en-zimas vegetales procedentes de celulas embionarias de grami-neas, solanaceas y rizomas.
Hnilica et al.	1961	Effect of Calf Thymus Histone on Rats bearing Transplantable Acute Myeloid Leukæmia

Legal Events

Date	Code	Title	Description
1994-11-15	UEP	Publication of translation of european patent specification
2011-01-15	EELA	Cancelled due to lapse of time